Can-Fite BioPharma Ltd. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Can-Fite BioPharma Ltd. (CANF) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.65 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-26
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 2.65M shares 20-F · filed 2026-03-26 | ||
| 2025-06-30 | 2.81B shares 6-K · filed 2025-08-28 | ||
| 2024-12-31 | 928.21K shares 20-F · filed 2026-03-26 | 2.78B shares 20-F · filed 2025-04-14 | |
| 2024-06-30 | 1.94B shares 6-K · filed 2025-08-28 | ||
| 2023-12-31 | 644.83K shares 20-F · filed 2026-03-26 | 1.93B shares 20-F · filed 2024-03-28 | |
| 2023-06-30 | 1.26B shares 6-K · filed 2024-08-29 | ||
| 2022-12-31 | 402.20M shares 20-F · filed 2025-04-14 | ||
| 2022-06-30 | 397.20M shares 6-K · filed 2022-08-25 | ||
| 2021-12-31 | 396.37M shares 20-F · filed 2024-03-28 | 18.42M shares 20-F · filed 2022-03-24 | |
| 2021-06-30 | 195.26M shares 6-K · filed 2022-08-25 | ||
| 2020-12-31 | 11.92M shares 20-F · filed 2022-03-24 | ||
| 2019-12-31 | 2.67M shares 20-F · filed 2022-03-24 | ||
| 2018-12-31 | 1.44M shares 20-F · filed 2021-03-25 |